Osteonecrosis of the mandible in a patient with lung adenocarcinoma undergoing anti‐angiogenic therapy with bevacizumab

作者：F Tzermpos; A Ismail; M Pavli; K I Tosios

来源：Oral Surgery, 2016, 9(1): 40-46.

DOI：10.1111/ors.12153

• adenocarcinoma
• bevacizumab
• lung
• ONJ
• osteonecrosis

Abstract(#br)Bevacizumab is a recombinant monoclonal humanised antibody, designed to inhibit the binding ability of vascular endothelial growth factor to its receptor. Recently bevacizumab has been implemented in the treatment protocols against certain types of cancer. A 63‐year‐old C aucasian male ...